Search Results 451-460 of 24213 for In situ
In a phase III clinical trial, 53% of patients with nonmuscle invasive bladder cancer (NMIBC) in the carcinoma in situ cohort had a complete response within ...
carcinoma in situ (DCIS) is an early form of a non-invasive breast cancer that begins as abnormal cells inside the milk ducts in the breast. It typically doesn' ...
Currently participating and receiving treatment in another study, or participated in ... in situ cervical carcinoma; Received a live vaccine within 30 days of ...
... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...
biopsy, Breast cancer, Lobular carcinoma in situ, Fibroadenoma, Breast pain, Atypical hyperplasia of the breast, Breast cysts and lumps, Phyllodes tumor.
... in participants with relapsed or refractory Hodgkin Lymphoma (HL). ... situ cervical cancer, ductal or lobular carcinoma in situ of the breast, or other ...
... in terms of progression-free survival in participants with relapsed or ... situ of the cervix, or breast, or other non-invasive lesion, that in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.